These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20155337)

  • 1. Pluripotent stem cells as source of dendritic cells for immune therapy.
    Senju S; Hirata S; Motomura Y; Fukuma D; Matsunaga Y; Fukushima S; Matsuyoshi H; Nishimura Y
    Int J Hematol; 2010 Apr; 91(3):392-400. PubMed ID: 20155337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotent stem cell-derived dendritic cells for immunotherapy.
    Senju S; Matsunaga Y; Fukushima S; Hirata S; Matsuyoshi H; Nishimura Y
    Front Biosci (Elite Ed); 2010 Jun; 2(4):1520-7. PubMed ID: 20515823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy with pluripotent stem cell-derived dendritic cells.
    Senju S; Matsunaga Y; Fukushima S; Hirata S; Motomura Y; Fukuma D; Matsuyoshi H; Nishimura Y
    Semin Immunopathol; 2011 Nov; 33(6):603-12. PubMed ID: 21461992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy.
    Fairchild PJ; Leishman A; Sachamitr P; Telfer C; Hackett S; Davies TJ
    Regen Med; 2015; 10(3):275-86. PubMed ID: 25933237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer immunotherapy by utilizing dedritic cells derived from pluripotent stem cells].
    Fukushima S; Ihn H; Nishimura Y; Senju S
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(3):113-20. PubMed ID: 21720099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3.
    Takacs E; Boto P; Simo E; Csuth TI; Toth BM; Raveh-Amit H; Pap A; Kovács EG; Kobolak J; Benkö S; Dinnyes A; Szatmari I
    J Immunol; 2017 Jan; 198(1):239-248. PubMed ID: 27852743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells.
    Senju S; Haruta M; Matsunaga Y; Fukushima S; Ikeda T; Takahashi K; Okita K; Yamanaka S; Nishimura Y
    Stem Cells; 2009 May; 27(5):1021-31. PubMed ID: 19415766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.
    Fukushima S; Hirata S; Motomura Y; Fukuma D; Matsunaga Y; Ikuta Y; Ikeda T; Kageshita T; Ihn H; Nishimura Y; Senju S
    J Immunother; 2009 Apr; 32(3):219-31. PubMed ID: 19242378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of mouse pluripotent stem cell-derived proliferating myeloid cells as an unlimited source of functional antigen-presenting cells.
    Zhang R; Liu TY; Senju S; Haruta M; Hirosawa N; Suzuki M; Tatsumi M; Ueda N; Maki H; Nakatsuka R; Matsuoka Y; Sasaki Y; Tsuzuki S; Nakanishi H; Araki R; Abe M; Akatsuka Y; Sakamoto Y; Sonoda Y; Nishimura Y; Kuzushima K; Uemura Y
    Cancer Immunol Res; 2015 Jun; 3(6):668-77. PubMed ID: 25672396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
    Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y
    Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer prevention with semi-allogeneic ES cell-derived dendritic cells.
    Fukuma D; Matsuyoshi H; Hirata S; Kurisaki A; Motomura Y; Yoshitake Y; Shinohara M; Nishimura Y; Senju S
    Biochem Biophys Res Commun; 2005 Sep; 335(1):5-13. PubMed ID: 16026756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro generation of human dendritic cells and cell therapy.
    Gluckman JC; Canque B; Chapuis F; Rosenzwajg M
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):187-96. PubMed ID: 9426977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.
    Silk KM; Silk JD; Ichiryu N; Davies TJ; Nolan KF; Leishman AJ; Carpenter L; Watt SM; Cerundolo V; Fairchild PJ
    Gene Ther; 2012 Oct; 19(10):1035-40. PubMed ID: 22071967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function.
    Senju S; Suemori H; Zembutsu H; Uemura Y; Hirata S; Fukuma D; Matsuyoshi H; Shimomura M; Haruta M; Fukushima S; Matsunaga Y; Katagiri T; Nakamura Y; Furuya M; Nakatsuji N; Nishimura Y
    Stem Cells; 2007 Nov; 25(11):2720-9. PubMed ID: 17690179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
    Foley R; Tozer R; Wan Y
    Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
    Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
    J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Production of Physiologic Dendritic Cells (phDC) for Immunotherapy.
    Hanlon D; Sobolev O; Han P; Ventura A; Vassall A; Kibbi N; Yurter A; Robinson E; Filler R; Tatsuno K; Edelson RL
    Methods Mol Biol; 2020; 2097():173-195. PubMed ID: 31776926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
    Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
    Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer vaccine therapy using genetically modified induced pluripotent stem cell-derived dendritic cells expressing the TAA gene].
    Iwamoto H; Ojima T; Nakamori M; Nakamura M; Hayata K; Katsuda M; Iida T; Miyazawa M; Iwahashi M; Yamaue H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1575-7. PubMed ID: 24393853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions.
    Su Z; Frye C; Bae KM; Kelley V; Vieweg J
    Clin Cancer Res; 2008 Oct; 14(19):6207-17. PubMed ID: 18829500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.